Evidence map›Paper›PMID 20046865›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2009

Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research.

Augustin Scalbert, Lorraine Brennan, Oliver Fiehn, Thomas Hankemeier, Bruce S Kristal, Ben van Ommen, Estelle Pujos-Guillot, Elwin Verheij, David Wishart, Suzan Wopereis

Registry-linked trialAbstract read
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01606683 (Impact of Infant Feeding on Newborn Metabolomic Profile), which is not on this map. Cited by 192 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01606683 nacompletednot on this mapstarted 2012, after this paper: background citation

Impact of Infant Feeding on Newborn Metabolomic Profile

TypeinterventionalSponsorHeinz Italia SpARan2012 to 2014Enrolled30ConditionsFormula Feeding of Healthy Full Term Infants, Breast Feeding of Healthy Full Term InfantsArmsInfant formula with GOS, beta-palmitate, acidified milk, Standard infant formula without functional ingredients, No intervention
3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Review
  12. Molecules (Basel, Switzerland) · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Phenotypic and metabonomics studies of FMOs in C. elegans and their roles in lifespan extension.Metabolomics : Official journal of the Metabolomic Society · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Augustin Scalbert
Lorraine Brennan
Oliver Fiehn
Thomas Hankemeier
Bruce S Kristal
Ben van Ommen
Estelle Pujos-Guillot
Elwin Verheij
David Wishart
Suzan Wopereis

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CHRISTOPHER P DUGGAN · 1994 to 2026
$31.6M
Caloric Restriction Biomarkers Predict Type II Diabetes?R01AG025872 · NIA · WINIFRED MASTERSON BURKE MED RES INST · PI KRISTAL, BRUCE S · 2005 to 2009
$2.6M
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk ProfilesU01ES016048 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI KRISTAL, BRUCE S · 2007 to 2010
$1.9M
Serum Metabolomic/Proteomic Profiles in CALERIER01AG028996 · NIA · WINIFRED MASTERSON BURKE MED RES INST · PI KRISTAL, BRUCE S · 2006 to 2010
$1.8M
Nutrition Modulated Metabolism as a Disease Risk FactorR01CA102536 · NCI · WINIFRED MASTERSON BURKE MED RES INST · PI KRISTAL, BRUCE S · 2005 to 2006
$1.2M
NCI NIH HHS R01 CA102536NIA NIH HHS R01 AG025872NIA NIH HHS R01 AG028996NIDDK NIH HHS P30 DK040561NIEHS NIH HHS U01 ES016048
6 · The paper itself

Abstract

Mass spectrometry (MS) techniques, because of their sensitivity and selectivity, have become methods of choice to characterize the human metabolome and MS-based metabolomics is increasingly used to characterize the complex metabolic effects of nutrients or foods. However progress is still hampered by many unsolved problems and most notably the lack of well established and standardized methods or procedures, and the difficulties still met in the identification of the metabolites influenced by a given nutritional intervention. The purpose of this paper is to review the main obstacles limiting progress and to make recommendations to overcome them. Propositions are made to improve the mode of collection and preparation of biological samples, the coverage and quality of mass spectrometry analyses, the extraction and exploitation of the raw data, the identification of the metabolites and the biological interpretation of the results.

Identifiers

PMID20046865
PMCPMC2794347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.